Clinical Trial Update: Study to Assess the Safety of BAY1067197 in Stable Heart Failure Patients on Standard Therapy Including ß-blocker [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the safety of BAY1067197 in stable heart failure patients on standard therapy including a beta-blocker has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• BAY1067197

Snippet

Sponsor: Bayer | Conditions: Heart Failure | Phase 2 | Status: COMPLETED